Important Dates
Early Bird Registration :7th April 2027
Paper Submission Deadline :12th April 2027
Last Date of Registration : 22nd April 2027
Date of Conference : 7th - 8th May 2027
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
Track 01
Virus Structure and Replication Dynamics
This track focuses on the molecular architecture of influenza viruses and their replication mechanisms. Understanding these processes is crucial for developing targeted antiviral therapies.
Track 02
Clinical Impact and Diagnostic Innovations
This session will explore the clinical manifestations of influenza and zoonotic diseases, along with advancements in diagnostic methodologies. Emphasis will be placed on improving early detection and patient management.
Track 03
Host-Virus Interactions and Pathogenesis
This track examines the complex interactions between influenza viruses and their hosts, shedding light on the mechanisms of pathogenesis. Insights gained will inform therapeutic strategies and vaccine development.
Track 04
Epidemics and Pandemic Preparedness
This session addresses the epidemiological patterns of influenza outbreaks and the global response to pandemic threats. Discussions will include strategies for surveillance, preparedness, and response planning.
Track 05
Immunological Responses to Influenza
This track delves into the immune responses elicited by influenza viruses, including both innate and adaptive immunity. Understanding these responses is essential for vaccine design and therapeutic interventions.
Track 06
Mathematical Modeling in Infectious Disease Dynamics
This session will highlight the role of mathematical modeling in understanding the spread of influenza and zoonotic diseases. Models can inform public health strategies and resource allocation during outbreaks.
Track 07
Antiviral Resistance Mechanisms
This track focuses on the emergence of antiviral resistance in influenza viruses and its implications for treatment. Discussions will include mechanisms of resistance and strategies to overcome these challenges.
Track 08
Epidemiology of Animal Influenza
This session will explore the ecology and epidemiology of influenza in animal populations. Understanding these dynamics is vital for predicting spillover events and managing zoonotic risks.
Track 09
Advancements in Vaccine Development
This track will cover current and novel approaches to influenza vaccine development, including new technologies and platforms. Evaluating the efficacy and safety of these vaccines will also be discussed.
Track 10
Risk Management and Mitigation Strategies
This session will focus on the assessment and management of risks associated with influenza outbreaks. Strategies for effective risk communication and public health interventions will be explored.
Track 11
Maternal Immunization and Public Health
This track examines the role of maternal immunization in protecting both mothers and infants from influenza. The session will discuss the implications for public health policy and maternal health strategies.